<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "1: past three years", fill: "#00ced1"},
{source: "1: past three years", target: "1: generated from operations", fill: "#00ced1"},
{source: "1: generated from operations", target: "1: operations", fill: "#00ced1"},
{source: "1: operations", target: "1: absent improving", fill: "#00ced1"},
{source: "1: absent improving", target: "1: raise additional", fill: "#00ced1"},
{source: "1: raise additional", target: "1: escrow obligations", fill: "#00ced1"},
{source: "1: past three years", target: "3: The Company ", fill: "#cb4154"},
{source: "3: The Company ", target: "3: total escrow deposits which", fill: "#cb4154"},
{source: "3: total escrow deposits which", target: "3: prior payments", fill: "#cb4154"},
{source: "3: prior payments", target: "3: cigarette sales", fill: "#cb4154"},
{source: "3: cigarette sales", target: "3: limit sales", fill: "#cb4154"},
{source: "3: The Company ", target: "4: future prospects", fill: "#cf1020"},
{source: "4: future prospects", target: "4: dependent", fill: "#cf1020"},
{source: "4: dependent", target: "4: significant", fill: "#cf1020"},
{source: "4: significant", target: "4: improvement", fill: "#cf1020"},
{source: "4: improvement", target: "4: discount cigarette", fill: "#cf1020"},
{source: "4: discount cigarette", target: "4: longer term on", fill: "#cf1020"},
{source: "4: longer term on", target: "4: distribution", fill: "#cf1020"},
{source: "4: distribution", target: "4: consumer acceptance", fill: "#cf1020"},
{source: "4: consumer acceptance", target: "4: lowTSNA smokeless tobacco products as well as", fill: "#cf1020"},
{source: "4: lowTSNA smokeless tobacco products as well as", target: "4: continued development", fill: "#cf1020"},
{source: "4: continued development", target: "4: through alliances", fill: "#cf1020"},
{source: "4: through alliances", target: "4: tobacco manufacturers", fill: "#cf1020"},
{source: "4: tobacco manufacturers", target: "4: particular on", fill: "#cf1020"},
{source: "4: particular on", target: "4: tobacco curing process", fill: "#cf1020"},
{source: "4: tobacco curing process", target: "4: exclusive licensee", fill: "#cf1020"},
{source: "4: future prospects", target: "5: dependent upon", fill: "#b78727"},
{source: "5: dependent upon", target: "5: successful completion", fill: "#b78727"},
{source: "5: successful completion", target: "5: ongoing patent infringement", fill: "#b78727"},
{source: "5: ongoing patent infringement", target: "5: lawsuit against", fill: "#b78727"},
{source: "5: lawsuit against", target: "5: generated by", fill: "#b78727"},
{source: "5: generated by", target: "5: operations continue", fill: "#b78727"},
{source: "5: operations continue", target: "5: significant demands on", fill: "#b78727"},
{source: "5: dependent upon", target: "6: common stock by entering into certain securities", fill: "#e4d96f"},
{source: "6: common stock by entering into certain securities", target: "6: registration rights agreements", fill: "#e4d96f"},
{source: "6: registration rights agreements", target: "6: Purchase Agreements ", fill: "#e4d96f"},
{source: "6: common stock by entering into certain securities", target: "11: cigarettes", fill: "#a4dded"},
{source: "11: cigarettes", target: "11: fourth quarters", fill: "#a4dded"},
{source: "11: fourth quarters", target: "11: negatively impacted by", fill: "#a4dded"},
{source: "11: negatively impacted by", target: "11: recent events", fill: "#a4dded"},
{source: "11: recent events", target: "11: Gulf Coast ", fill: "#a4dded"},
{source: "11: Gulf Coast ", target: "11: by continued pressure on", fill: "#a4dded"},
{source: "11: by continued pressure on", target: "11: deep discount", fill: "#a4dded"},
{source: "11: deep discount", target: "11: cigarette market", fill: "#a4dded"},
{source: "11: cigarette market", target: "11: four nonMSA", fill: "#a4dded"},
{source: "11: cigarettes", target: "13: successful completion", fill: "#ff6347"},
{source: "13: successful completion", target: "13: ongoing patent infringement", fill: "#ff6347"},
{source: "13: ongoing patent infringement", target: "13: lawsuit against", fill: "#ff6347"},
{source: "13: lawsuit against", target: "13: improvement", fill: "#ff6347"},
{source: "13: improvement", target: "13: significant", fill: "#ff6347"},
{source: "13: significant", target: "13: cigarette", fill: "#ff6347"},
{source: "13: cigarette", target: "13: necessary", fill: "#ff6347"},
{source: "13: necessary", target: "13: additional", fill: "#ff6347"},
{source: "13: successful completion", target: "14: depending upon market conditions", fill: "#bc987e"},
{source: "14: depending upon market conditions", target: "14: common stock", fill: "#bc987e"},
{source: "14: common stock", target: "14: seek additional funds", fill: "#bc987e"},
{source: "14: depending upon market conditions", target: "24: approximately", fill: "#98817b"},
{source: "24: approximately", target: "24: each carton", fill: "#98817b"},
{source: "24: each carton", target: "24: cigarettes sold by us effective", fill: "#98817b"},
{source: "24: cigarettes sold by us effective", target: "24: comparable cost", fill: "#98817b"},
{source: "24: comparable cost", target: "24: smokeless products which will", fill: "#98817b"},
{source: "24: smokeless products which will", target: "24: continue over", fill: "#98817b"},
{source: "24: continue over", target: "24: tenyear life", fill: "#98817b"},
{source: "24: approximately", target: "25: assessments", fill: "#ffc40c"},
{source: "25: assessments", target: "25: certain loan loss costs", fill: "#ffc40c"},
{source: "25: certain loan loss costs", target: "25: administration costs", fill: "#ffc40c"},
{source: "25: assessments", target: "28: profits from cigarette", fill: "#446ccf"},
{source: "28: profits from cigarette", target: "28: earn net income", fill: "#446ccf"},
{source: "28: earn net income", target: "28: cash flow from", fill: "#446ccf"},
{source: "28: cash flow from", target: "28: operations will depend on", fill: "#446ccf"},
{source: "28: operations will depend on", target: "28: revenues from royalties", fill: "#446ccf"},
{source: "28: revenues from royalties", target: "28: smokeless tobacco products which", fill: "#446ccf"},
{source: "28: smokeless tobacco products which", target: "28: provided only de", fill: "#446ccf"},
{source: "28: provided only de", target: "28: minimis revenues", fill: "#446ccf"},
{source: "28: profits from cigarette", target: "31: Beginning in September ", fill: "#339"},
{source: "31: Beginning in September ", target: "31: introduced three new smokeless tobacco", fill: "#339"},
{source: "31: introduced three new smokeless tobacco", target: "31: Stonewall ", fill: "#339"},
{source: "31: Stonewall ", target: "31: hard tobacco", fill: "#339"},
{source: "31: Beginning in September ", target: "33: STONEWALL Hard Snuff ", fill: "#808080"},
{source: "33: STONEWALL Hard Snuff ", target: "33: significant sales", fill: "#808080"},
{source: "33: significant sales", target: "33: smokeless tobacco products", fill: "#808080"},
{source: "33: STONEWALL Hard Snuff ", target: "62: As the US ", fill: "#ed1c24"},
{source: "62: As the US ", target: "62: cigarette market continues", fill: "#ed1c24"},
{source: "62: cigarette market continues", target: "62: trend could adversely affect", fill: "#ed1c24"},
{source: "62: trend could adversely affect", target: "62: sales volumes", fill: "#ed1c24"},
{source: "62: sales volumes", target: "62: cash flows", fill: "#ed1c24"},
{source: "62: As the US ", target: "67: encountered significant competition from several", fill: "#e5b73b"},
{source: "67: encountered significant competition from several", target: "67: manufacturers", fill: "#e5b73b"},
{source: "67: manufacturers", target: "67: cigarettes as well as importers", fill: "#e5b73b"},
{source: "67: cigarettes as well as importers", target: "67: cigarettes", fill: "#e5b73b"},
{source: "67: cigarettes", target: "67: manufactured", fill: "#e5b73b"},
{source: "67: manufactured", target: "67: foreign countries", fill: "#e5b73b"},
{source: "67: encountered significant competition from several", target: "START_HERE", fill: "#e5b73b"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Home Improvement Retail</td>
    </tr>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Automobile Manufacturers</td>
    </tr>
    <tr>
      <td>Motorcycle Manufacturers</td>
    </tr>
    <tr>
      <td>Advertising</td>
    </tr>
    <tr>
      <td>Independent Power Producers and Energy Traders</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Investment Banking and Brokerage</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Consult</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Offer peace proposal</td>
    </tr>
    <tr>
      <td>Accuse</td>
    </tr>
    <tr>
      <td>Reward</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Complain</td>
    </tr>
    <tr>
      <td>Pessimistic comment</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Military blockade</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operating_cash_flow">Operating cash flow</a></td>
      <td>In financial accounting, operating cash flow (OCF), cash flow provided by operations, cash flow from operating activities (CFO) or free cash flow from operations (FCFO), refers to the amount of cash a company generates from the revenues it brings in, excluding costs associated with long-term investment on capital items or investment in securities. Operating activities include any spending or sources of cash that’s involved in a company’s day-to-day business activities.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_management">Operations management</a></td>
      <td>Operations management is an area of management concerned with designing and controlling the process of production and redesigning business operations in the production of goods or services. It involves the responsibility of ensuring that business operations are efficient in terms of using as few resources as needed and effective in meeting customer requirements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Condor">Operation Condor</a></td>
      <td>Operation Condor (Spanish: Operación Cóndor, also known as Plan Cóndor; Portuguese: Operação Condor) was a United States-backed campaign of political repression and state terror involving intelligence operations and assassination of opponents. It was officially and formally implemented in November 1975 by the right-wing dictatorships of the Southern Cone of South America.Due to its clandestine nature, the precise number of deaths directly attributable to Operation Condor is highly disputed.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Stock_market">Stock market</a></td>
      <td>A stock market, equity market, or share market is the aggregation of buyers and sellers of stocks (also called shares), which represent ownership claims on businesses; these may include securities listed on a public stock exchange, as well as stock that is only traded privately, such as shares of private companies which are sold to investors through equity crowdfunding platforms. Investment is usually made with an investment strategy in mind.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Company">Company</a></td>
      <td>A company, abbreviated as co., is a legal entity representing an association of people, whether natural, legal or a mixture of both, with a specific objective. Company members share a common purpose and unite to achieve specific, declared goals.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Tobacco_smoking">Tobacco smoking</a></td>
      <td>Tobacco smoking is the practice of burning tobacco and ingesting the smoke that is produced. The smoke may be inhaled, as is done with cigarettes, or simply released from the mouth, as is generally done with pipes and cigars.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Tobacco">Tobacco</a></td>
      <td>Tobago () is an island and ward within the Republic of Trinidad and Tobago. It is located 35 kilometres (22 mi) northeast of the larger island of Trinidad and about 160 kilometres (99 mi) off the northeastern coast of Venezuela.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Safety_of_electronic_cigarettes">Safety of electronic cigarettes</a></td>
      <td>The use of electronic cigarettes (vaping) carries many health risks, especially for children, young adults, and pregnant women. The risk depends on the composition of electronic cigarette aerosol and varies according to the contents of the liquid, the physical and electrical design of the device, and user behavior.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/U.S._Smokeless_Tobacco_Company">U.S. Smokeless Tobacco Company</a></td>
      <td>U.S. Smokeless Tobacco Company (formerly United States Tobacco Company) manufactures smokeless tobacco products, notably dipping tobacco, but also chewing tobacco, snus, and dry snuff and is a subsidiary of Altria.\nIts corporate headquarters are located in Richmond, Virginia, and it maintains factories in Clarksville and Nashville, Tennessee, Franklin Park, Illinois, and Hopkinsville, Kentucky.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Chewing_tobacco">Chewing tobacco</a></td>
      <td>Chewing tobacco is a type of smokeless tobacco product that is placed between the cheek and lower gum to draw out its flavor. Some users chew it, others do not.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_tobacco_products">List of tobacco products</a></td>
      <td>The following is an incomplete list of tobacco products.\nTobacco is the agricultural product of the leaves of plants in the genus Nicotiana.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Lawsuit">Lawsuit</a></td>
      <td>A lawsuit is a proceeding by a party or parties against another in the civil court of law. The archaic term "suit in law" is found in only a small number of laws still in effect today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Cigarettes_After_Sex">Cigarettes After Sex</a></td>
      <td>Cigarettes After Sex is an American dream pop band formed in El Paso, Texas, in 2008 by Greg Gonzalez. The band is known for their ethereal, limerent and often dream-like musical style, lyrics often based on the themes of romance and love, as well as Gonzalez's voice, which has been described as "androgynous".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Herbal_cigarette">Herbal cigarette</a></td>
      <td>Herbal cigarettes (also called tobacco-free cigarettes or nicotine-free cigarettes) are cigarettes that usually do not contain any tobacco or nicotine, instead being composed of a mixture of various herbs and/or other plant material. However, Chinese herbal cigarettes contain tobacco and nicotine with herbs added, unlike European and North American herbal cigarettes which have tobacco and nicotine omitted.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_cigarette_brands">List of cigarette brands</a></td>
      <td>This is a list of current cigarette brands.  Factory-made cigarettes, when contrasted to roll-your-own cigarettes, are called tailor mades.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Candy_cigarette">Candy cigarette</a></td>
      <td>Candy cigarettes are a candy introduced in the late 19th century made out of chalky sugar, bubblegum or chocolate, wrapped in paper and packaged and branded so as to resemble cigarettes. Some products contain powdered sugar hidden in the wrapper, allowing the user to blow into the cigarette and produce a cloud of sugar that imitates smoke, which comes out of the other end.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Marlboro">Marlboro</a></td>
      <td>Marlboro (US: , UK: ) is an American brand of cigarettes, currently owned and manufactured by Philip Morris USA (a branch of Altria) within the United States, and by Philip Morris International (now separate from Altria) outside the United States. The largest Marlboro cigarette manufacturing plant is located in Richmond, Virginia.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Camel_(cigarette)">Camel (cigarette)</a></td>
      <td>Camel is an American brand of cigarettes, currently owned and manufactured by the R. J. Reynolds Tobacco Company in the United States and by Japan Tobacco outside the U.S.Most current Camel cigarettes contain a blend of Turkish tobacco and Virginia tobacco. Winston-Salem, North Carolina, the city where R. J. Reynolds was founded, is nicknamed "Camel City" because of the brand's popularity.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Death_(cigarette)">Death (cigarette)</a></td>
      <td>Death was a British brand of cigarettes which was owned and manufactured by the Enlightened Tobacco Company in the United Kingdom from 1991 to 1999.  It was conceived as a satirical statement on cigarette marketing and advertising, intended to criticize or reveal the true intent of cigarette marketing: namely, the idea that cigarettes were a product that, when consumed in the manner for which they had been manufactured, were essentially fatal and likely to contribute to the death of the person smoking them.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Common_stock_dividend">Common stock dividend</a></td>
      <td>A common stock dividend is the dividend paid to common stock owners from the profits of the company.  Like other dividends, the payout is in the form of either cash or stock.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Matthiola_incana">Matthiola incana</a></td>
      <td>Matthiola incana is a species of flowering plant in the cabbage family Brassicaceae. Common names include Brompton stock, common stock, hoary stock, ten-week stock, and gilly-flower.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Treasury_stock">Treasury stock</a></td>
      <td>A treasury stock or reacquired stock is stock which is bought back by the issuing company, reducing the amount of outstanding stock on the open market ("open market" including insiders' holdings). \nStock repurchases are used as a tax efficient method to put cash into shareholders' hands, rather than paying dividends, in jurisdictions that treat capital gains more favorably.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Dipping_tobacco">Dipping tobacco</a></td>
      <td>Dipping tobacco  is a type of finely ground or shredded, moistened smokeless tobacco product. It is commonly and idiomatically known as "dip".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Skoal_(tobacco)">Skoal (tobacco)</a></td>
      <td>Skoal is a brand of moist smokeless tobacco. Skoal is produced by the U.S. Smokeless Tobacco Company (USSTC), which is a subsidiary of Altria.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Summative_assessment">Summative assessment</a></td>
      <td>Summative assessment, summative evaluation, or assessment of learning is the assessment of participants where the focus is on the outcome of a program. This contrasts with formative assessment, which summarizes the participants' development at a particular time.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Formative_assessment">Formative assessment</a></td>
      <td>Formative assessment, formative evaluation, formative feedback, or assessment for learning, including diagnostic testing, is a range of formal and informal assessment procedures conducted by teachers during the learning process in order to modify teaching and learning activities to improve student attainment. The goal of a formative assessment is to monitor student learning to provide ongoing feedback that can help students identify their strengths and weaknesses and target areas that need work.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Risk_assessment">Risk assessment</a></td>
      <td>Broadly speaking, a risk assessment is the combined effort of:\n\nidentifying and analyzing potential (future) events that may negatively impact individuals, assets, and/or the environment (i.e. hazard analysis); and\nmaking judgments "on the tolerability of the risk on the basis of a risk analysis" while considering influencing factors (i.e.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Free_cash_flow">Free cash flow</a></td>
      <td>In corporate finance, free cash flow (FCF) or free cash flow to firm (FCFF) is the amount by which a business's operating cash flow exceeds its working capital needs and expenditures on fixed assets (known as capital expenditures). It is that portion of cash flow that can be extracted from a company and distributed to creditors and securities holders  without causing issues in its operations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Cash_flow_forecasting">Cash flow forecasting</a></td>
      <td>Cash flow forecasting  is the process of obtaining an estimate or forecast of a company's future financial position; the cash flow forecast is typically based on anticipated payments and receivables.\nSee Financial forecast for general discussion re methodology.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Free_cash_flow_to_equity">Free cash flow to equity</a></td>
      <td>In corporate finance, free cash flow to equity (FCFE) is a metric of how much cash can be distributed to the equity shareholders of the company as dividends or stock buybacks—after all expenses, reinvestments, and debt repayments are taken care of. It is also referred to as the levered free cash flow or the flow to equity (FTE).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Tobacco_harm_reduction">Tobacco harm reduction</a></td>
      <td>Tobacco harm reduction (THR) is a public health strategy to lower the health risks to individuals and wider society associated with using tobacco products. It is an example of the concept of harm reduction, a strategy for dealing with the use of drugs.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Dissolvable_tobacco">Dissolvable tobacco</a></td>
      <td>Dissolvable tobacco is a tobacco product. Unlike ordinary chewing tobacco, it dissolves in the mouth.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Cash_flow_loan">Cash flow loan</a></td>
      <td>A cash flow loan is a type of debt financing, in which a bank lends funds, generally for working capital, using the expected cash flows that a borrowing company generates as collateral for the loan. Cashflow loans are usually senior term loans or subordinated debt, being used for funding growth or financing an acquisition.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Manufacturing">Manufacturing</a></td>
      <td>Manufacturing is the creation or production of goods with the help of equipment, labor, machines, tools, and chemical or biological processing or formulation. It is the essence of secondary sector of the economy.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>STAR SCIENTIFIC INC      Item 1A Risk Factors        The Company’s business has been operating at a loss for the <font color="blue">past three years</font>     and continues to use more cash than is being <font color="blue">generated from <font color="blue">operations</font></font>;     <font color="blue">absent improving</font> results of <font color="blue">operations</font>, we will need to <font color="blue">raise <font color="blue">additional</font></font>     capital in early 2007 to meet working capital and MSA <font color="blue">escrow <font color="blue"><font color="blue">obligation</font>s</font></font>        The  Company has been operating at a loss for the <font color="blue">past three years</font></td>
    </tr>
    <tr>
      <td>In     addition, <font color="blue">the Company </font>is required to make annual MSA <font color="blue">escrow payments</font> that     are not accounted for in working capital</td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>expects this year’s     total escrow deposits (which are due in April 2006 for 2005 sales) to be     <font color="blue">approximately</font> dlra1dtta5 million based on its <font color="blue">prior payments</font>, a decrease in total     <font color="blue"><font color="blue">cigarette</font> sales</font> in 2005 and its efforts to <font color="blue">limit sales</font> in MSA states</td>
    </tr>
    <tr>
      <td>Our <font color="blue">future prospects</font> are <font color="blue">dependent</font>, in the near term, on a <font color="blue">significant</font>     <font color="blue">improvement</font> in the expected performance of our <font color="blue">discount <font color="blue">cigarette</font></font> business     and, in the longer term, on the <font color="blue">distribution</font> and <font color="blue">consumer <font color="blue">acceptance</font></font> of our     low-TSNA <font color="blue">smokeless <font color="blue">tobacco product</font>s</font> as well as the <font color="blue">continued <font color="blue">development</font></font> of     new low-TSNA <font color="blue">smokeless <font color="blue">tobacco product</font>s</font>, in<font color="blue">dependent</font>ly and <font color="blue">through alliances</font>     with other <font color="blue">tobacco <font color="blue"><font color="blue">manufacture</font>rs</font></font>, and, in particular, on our ability to     begin generating <font color="blue">significant</font> revenues through royalties from the patented     <font color="blue">tobacco curing process</font> to which we are the <font color="blue">exclusive licensee</font></td>
    </tr>
    <tr>
      <td>However, our     ability to generate revenues through such royalty payments will also be     <font color="blue">dependent</font> upon the <font color="blue">successful completion</font> of our <font color="blue">ongoing patent <font color="blue">infringement</font></font>     <font color="blue">lawsuit against</font> RJR       The  recurring  losses  <font color="blue">generated by</font> our <font color="blue">operations</font> continue to impose     <font color="blue">significant</font> demands on our liquidity</td>
    </tr>
    <tr>
      <td>In 2005, we generated dlra18dtta0 million     through the sale of our <font color="blue"><font color="blue">common stock</font> by entering into certain securities</font>     purchase and <font color="blue">registration rights <font color="blue">agreements</font></font> (“the Purchase Agreements”) and     dlra7dtta6  million  through  exercise of warrants issued under the Purchase     Agreements</td>
    </tr>
    <tr>
      <td>In March 2006, we completed an <font color="blue">equity sale</font> for dlra6dtta0 million,     dlra600cmam000 of which was paid at closing and the remainder of which is being     paid in <font color="blue">installments over</font> a <font color="blue">four month period</font></td>
    </tr>
    <tr>
      <td>Also, we have outstanding     warrants  that  we have <font color="blue">issued pursuant</font> to the <font color="blue">Purchase Agreements </font>for     1dtta7 million shares of <font color="blue">common stock</font> with an <font color="blue">exercise price</font> of dlra5dtta25 per share     which expire in March 2006, warrants for 1dtta9 million shares of stock with an     <font color="blue">exercise price</font> of dlra4dtta00 per share which expire in June 2006, and warrants     for 2dtta0 million shares of stock with an <font color="blue">exercise price</font> of dlra3dtta00 per share     which expire in June 2007</td>
    </tr>
    <tr>
      <td>If all of the warrants are exercised prior to     their expiration, this will generate an <font color="blue">additional</font> dlra22dtta4 million, although     any decision to exercise the warrants is not within our control and will     <font color="blue">depend primarily on</font> the performance of our <font color="blue">stock price during</font> the exercise     periods</td>
    </tr>
    <tr>
      <td>With the proceeds of the Company’s <font color="blue">financings</font> in 2005 and the March 2006     dlra6dtta0 million stock sale, we anticipate that we will have <font color="blue">sufficient funds</font> to     support  our <font color="blue">operations</font> into early 2007, <font color="blue">notwithstanding</font> a <font color="blue">significant</font>     downturn in sales of <font color="blue">discount <font color="blue">cigarette</font></font>s the third and <font color="blue">fourth quarters</font> of     2005  <font color="blue">attributable</font>,  in  part, to the recent <font color="blue">Gulf Coast </font>hurricanes and     <font color="blue">continued competition</font> in the non-MSA states</td>
    </tr>
    <tr>
      <td>Based on sales of discount     <font color="blue"><font color="blue">cigarette</font>s</font> in the third and <font color="blue">fourth quarters</font> of 2005, it is anticipated that     sales in 2006 will continue to be <font color="blue">negatively impacted by</font> the <font color="blue">recent events</font>     in the <font color="blue">Gulf Coast </font>states and <font color="blue">by continued pressure on</font> the <font color="blue">deep discount</font>     <font color="blue"><font color="blue">cigarette</font> market</font> in the four non-MSA states</td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>has taken a number     of  steps  to address the decline in <font color="blue"><font color="blue">cigarette</font> sales</font> volume, including     limiting the amount of promotional spending, consolidating and revamping its     <font color="blue">sales force</font> in Texas and, to a <font color="blue">lesser extent</font>, in Florida and Minnesota, and     downsizing the workforce at our Petersburg, Virginia <font color="blue"><font color="blue">cigarette</font> factory</font></td>
    </tr>
    <tr>
      <td>However, absent the <font color="blue">successful completion</font> of our <font color="blue">ongoing patent <font color="blue">infringement</font></font>     <font color="blue">lawsuit against</font> RJR, the exercise of outstanding warrants, a substantial     <font color="blue">improvement</font> in revenues and/or royalties from <font color="blue">smokeless <font color="blue">tobacco product</font>s</font>, or     a <font color="blue">significant</font> <font color="blue">improvement</font> of our expected volume of <font color="blue"><font color="blue">cigarette</font> sales</font>, we     believe that it will be <font color="blue">necessary</font> to pursue <font color="blue">additional</font> sources of funds in     early 2007</td>
    </tr>
    <tr>
      <td>However, <font color="blue">depending upon <font color="blue">market conditions</font></font> and the price of our     <font color="blue">common stock</font>, we may decide to seek <font color="blue">additional</font> funds before early 2007</td>
    </tr>
    <tr>
      <td>Our <font color="blue">cigarette</font> business, which has generated a substantial majority of our     revenues in the past, continues to experience declines in <font color="blue">shipments as well</font>     <font color="blue">as increased market pressures</font> and we may not be able to reverse this trend        A substantial majority of our <font color="blue">revenues historically</font> has <font color="blue">been derived from</font>     sales of our <font color="blue">discount <font color="blue">cigarette</font></font>s which are sold though Star Tobacco, Inc</td>
    </tr>
    <tr>
      <td>Since 2000, however, our discount     <font color="blue">cigarette</font> business has experienced a <font color="blue">significant</font> decline in sales, partly     caused by intensified pricing competition from foreign <font color="blue"><font color="blue">manufacture</font>rs</font> (see     “<font color="blue">Competition </font>from other tobacco companies has <font color="blue"><font color="blue">adversely</font> affected us</font> and may     continue to do so”)</td>
    </tr>
    <tr>
      <td>Despite our efforts to reenergize <font color="blue"><font color="blue">cigarette</font> sales</font>, shipments in 2005 and in     2006 to date have continued to <font color="blue">decline compared</font> to <font color="blue">prior years</font> and we face     potential  and  actual  increases  in <font color="blue">regulatory</font> and <font color="blue">excise tax costs</font></td>
    </tr>
    <tr>
      <td>Accordingly, we <font color="blue">cannot guarantee</font> we will be able to reverse the downward     trend in our <font color="blue">discount <font color="blue">cigarette</font></font> business</td>
    </tr>
    <tr>
      <td><font color="blue">Notwithstanding </font>the declining     performance of our <font color="blue">discount <font color="blue">cigarette</font></font> business, we will continue to focus     our principal efforts on the sale of <font color="blue">discount <font color="blue">cigarette</font></font>s in the four non-MSA     states for the <font color="blue">foreseeable future</font></td>
    </tr>
    <tr>
      <td>At the same time, we will continue to     evaluate  the  prospects  for our <font color="blue">cigarette</font> business in general and in     particular, sales in MSA states, given the <font color="blue">additional</font> <font color="blue">regulatory</font> and MSA     burdens of operating in those states</td>
    </tr>
    <tr>
      <td>21     ______________________________________________________________________    [45]Table of Contents       In addition, we must pay a substantial portion of our gross <font color="blue">profits on</font>     <font color="blue"><font color="blue">cigarette</font> sales</font> into escrow in April of <font color="blue">each year</font> to meet our <font color="blue"><font color="blue">obligation</font>s</font>     under <font color="blue">the MSA Because </font>the funds deposited into escrow are not available to     meet our other cash needs, even if we were able to generate net income from     our <font color="blue">cigarette</font> business, we would not <font color="blue">necessarily</font> generate positive cash flow     from  <font color="blue">operations</font>,  when  taking  into  account  these <font color="blue">escrow payments</font></td>
    </tr>
    <tr>
      <td>Additionally,  beginning in January 2005 we have been required to make     <font color="blue">further payments pursuant</font> to the <font color="blue">tobacco farmer <font color="blue">buyout program</font> which</font> were     not  required  in  previous  years</td>
    </tr>
    <tr>
      <td>This  program has added a cost of     <font color="blue">approximately</font>  dlra0dtta50 to <font color="blue">each carton</font> of <font color="blue"><font color="blue">cigarette</font>s</font> sold by us <font color="blue">effective</font>     January 1, 2005 and a <font color="blue">comparable cost</font> for <font color="blue"><font color="blue">smokeless products</font> which will</font>     <font color="blue">continue over</font> the ten-year life of the program</td>
    </tr>
    <tr>
      <td>As part of this program, we     also  will  be  subject to <font color="blue"><font color="blue">assessment</font>s</font> for <font color="blue">certain loan loss costs</font> and     <font color="blue">administration costs</font></td>
    </tr>
    <tr>
      <td>These <font color="blue"><font color="blue">assessment</font>s</font> will be recorded when received and     <font color="blue">paid over several</font> quarters, rather than over the life of the <font color="blue">buyout program</font></td>
    </tr>
    <tr>
      <td>We believe that it will take over a year to assess the affect the <font color="blue">buyout may</font>     have <font color="blue">on tobacco cultivation</font> and sales</td>
    </tr>
    <tr>
      <td>If we are not able to increase our revenues and gross profits from <font color="blue">cigarette</font>     sales, our ability to <font color="blue">earn net income</font> and generate positive <font color="blue">cash flow from</font>     <font color="blue">operations</font> will depend on our ability to grow our <font color="blue">revenues from royalties</font>     and sales of our <font color="blue">smokeless <font color="blue">tobacco product</font>s</font>, which have <font color="blue">provided only de</font>     <font color="blue">minimis revenues</font> to date</td>
    </tr>
    <tr>
      <td>Our prospects for <font color="blue">success as</font> a <font color="blue">technology</font>-oriented tobacco company with a     mission to <font color="blue">reduce toxins</font> in <font color="blue">tobacco leaf</font> and <font color="blue">tobacco smoke</font> are <font color="blue">dependent</font>,     over the long term, on the <font color="blue">distribution</font> and <font color="blue">consumer <font color="blue">acceptance</font></font> of our very     low-TSNA <font color="blue">smokeless <font color="blue">tobacco product</font>s</font>, as well as the <font color="blue">continued <font color="blue">development</font></font> of     new very low-TSNA <font color="blue">smokeless <font color="blue">tobacco product</font>s</font>, in<font color="blue">dependent</font>ly and through     alliances with <font color="blue">tobacco <font color="blue"><font color="blue">manufacture</font>rs</font></font> and <font color="blue">potentially</font> other <font color="blue">third parties</font>        We have <font color="blue">previously</font> announced our plan to <font color="blue">concentrate</font> our long-term efforts     on our very low-TSNA <font color="blue">smokeless <font color="blue">tobacco product</font>s</font>, our receipt of <font color="blue">royalty fees</font>     for <font color="blue"><font color="blue">hard tobacco</font> products</font> and on licensing our <font color="blue">patented <font color="blue">technology</font></font> for     producing low-TSNA tobacco</td>
    </tr>
    <tr>
      <td><font color="blue"><font color="blue">Beginning </font>in September </font>2001, we <font color="blue">introduced three new smokeless tobacco</font>     products,  Stonewall^®  moist  and dry snuffs and ARIVA^® <font color="blue">hard tobacco</font>     cigalett^® pieces</td>
    </tr>
    <tr>
      <td><font color="blue">Beginning </font>in the <font color="blue">second quarter</font> of 2003, we began a     <font color="blue">commercial test market</font> of a new, non-fermented spit-free^® “<font color="blue">hard tobacco</font>”     product for <font color="blue">moist snuff</font> users, called <font color="blue">STONEWALL Hard Snuff</font>^®</td>
    </tr>
    <tr>
      <td>By the end of     2004, <font color="blue">STONEWALL Hard Snuff</font>^® was available in <font color="blue">approximately</font> 7cmam000 locations     that  have  <font color="blue">significant</font> sales of <font color="blue">smokeless <font color="blue">tobacco product</font>s</font></td>
    </tr>
    <tr>
      <td>Given the     Company’s decision to focus on hard snuff <font color="blue">smokeless <font color="blue">tobacco product</font>s</font>, the     Company has <font color="blue">discontinued <font color="blue">manufacturing</font></font> Stonewall^® <font color="blue">moist snuff</font> and is not     <font color="blue">actively marketing</font> Stonewall dry snuff</td>
    </tr>
    <tr>
      <td>To date, sales of our <font color="blue">smokeless products</font> have <font color="blue">been slower than</font> expected, in     part, we believe, due to the lack of consumer awareness of those products,     <font color="blue">particularly</font> ARIVA^® and <font color="blue">STONEWALL Hard Snuff</font>^® and lack of sufficient     capital to increase consumer awareness of and <font color="blue">acceptance</font> of those products</td>
    </tr>
    <tr>
      <td>It is not <font color="blue">certain whether</font> our low-TSNA <font color="blue">smokeless <font color="blue">tobacco product</font>s</font> will be     <font color="blue">accepted by</font> the market in <font color="blue">sufficient volume</font> to support our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue">Adult     </font>tobacco users may decide not to purchase our products due to taste or other     <font color="blue">preferences</font>, or because of the extensive <font color="blue">health warnings contained on</font> the     packaging for our products</td>
    </tr>
    <tr>
      <td>Our efforts to <font color="blue">successfully market</font> ARIVA^® and     <font color="blue">STONEWALL Hard Snuff</font>^® will require the <font color="blue">expenditure</font> of substantial funds,     which we will need to obtain <font color="blue">from external financing</font>, the <font color="blue">availability</font> of     <font color="blue">which cannot</font> be assured, and ultimately these <font color="blue">products may</font> not be accepted     in the <font color="blue">national marketplace</font></td>
    </tr>
    <tr>
      <td><font color="blue">If <font color="blue">the Company </font></font>is not successful in its efforts to offer very low-TSNA     <font color="blue">smokeless <font color="blue">tobacco product</font>s</font> to <font color="blue">adults as <font color="blue">alternative</font>s</font> to <font color="blue"><font color="blue">cigarette</font>s</font> and other     <font color="blue">smokeless products</font> or <font color="blue">generate revenue through</font> the related <font color="blue">technology</font> to     which we are the <font color="blue">exclusive licensee</font>, we will not have <font color="blue">sufficient sales</font> of     other products to offset declining <font color="blue"><font color="blue">cigarette</font>s</font> revenues</td>
    </tr>
    <tr>
      <td>This <font color="blue">would <font color="blue">adversely</font></font>     affect our <font color="blue">sales volumes</font>, operating income and <font color="blue">cash flows</font>, as well as our     ability to pay our debts</td>
    </tr>
    <tr>
      <td>The <font color="blue"><font color="blue">combination</font> transaction between</font> RJR and B&amp;W <font color="blue">may impact negatively upon</font>     <font color="blue">the Company </font>       On July 30, 2004, RJR, a subsidiary of B&amp;W, and certain of their <font color="blue">affiliated</font>     tobacco <font color="blue">businesses</font> combined <font color="blue">operations</font> under the new publicly traded holding     company, Reynolds American Inc, which is 42prca owned by British American     Tobacco PLC, the parent company of B&amp;W Star and B&amp;W have <font color="blue">been party</font> to     multiple, substantial <font color="blue">commercial relationships</font> for a number of years, and     <font color="blue">Star and RJR </font>are <font color="blue">currently involved</font> in <font color="blue">significant</font> patent <font color="blue">infringement</font>     <font color="blue">litigation</font>,  the  trial  of  <font color="blue">which commenced</font> in <font color="blue">US District Court </font>on     January 31, 2005</td>
    </tr>
    <tr>
      <td>During the pending patent <font color="blue">litigation</font> described above, RJR     took  the  position  that  the new operating entity resulting from the     <font color="blue">combination</font> of RJR and B&amp;W, assumed all of the rights and <font color="blue"><font color="blue">obligation</font>s</font> under     the <font color="blue">agreements</font> <font color="blue">previously</font> entered into between Star and B&amp;W, and moved to     dismiss our patent <font color="blue">infringement</font> case on this basis</td>
    </tr>
    <tr>
      <td>After full briefing the     Court denied RJR’s motion to dismiss, and found that B&amp;W had attempted to     assign the Star/B&amp;W <font color="blue">agreements</font> to the <font color="blue">new subsidiary</font>, and that Star had not     consented to the <font color="blue">assignment</font></td>
    </tr>
    <tr>
      <td><font color="blue">The Court </font><font color="blue">further found</font> that the de facto     <font color="blue">merger doctrine</font> did not apply</td>
    </tr>
    <tr>
      <td>In its ruling the Court did <font color="blue">leave open</font> the     question of what impact, if any, the <font color="blue">combination</font> may have on the future     <font color="blue">licensing <font color="blue">arrangements</font> with</font> RJR, but noted that those <font color="blue">considerations</font> did not     <font color="blue">impact on</font> the claims asserted in the present <font color="blue">litigation</font></td>
    </tr>
    <tr>
      <td>22     ______________________________________________________________________    [46]Table of Contents       We have had important <font color="blue">relationships with</font> B&amp;W        Prior  to  the  <font color="blue">combination</font>  of B&amp;W and RJR, we had important business     <font color="blue">relationships with</font> B&amp;W, including licensing and royalty <font color="blue">agreements</font> relating     to the purchase of StarCured^® tobacco and other low-TSNA tobacco as well as     the financing of <font color="blue">curing barns</font></td>
    </tr>
    <tr>
      <td>Under  our  Restated  Master  Agreement with B&amp;W, <font color="blue">as amended by letter</font>     <font color="blue">agreements</font>  dated  <font color="blue">December </font>4,  2002  and  August 14, 2003, we owe B&amp;W     <font color="blue">approximately</font> dlra20 million of long-term debt</td>
    </tr>
    <tr>
      <td><font color="blue">Beginning </font>January 1, 2006,     <font color="blue">interest began accruing on</font> the debt at prime plus 1prca and we began making     <font color="blue">payments on</font> the <font color="blue">principal balance</font> of the debt</td>
    </tr>
    <tr>
      <td>These payments are due in 96     <font color="blue">monthly installments</font></td>
    </tr>
    <tr>
      <td>The debt is secured by <font color="blue">tobacco leaf</font> inventory and a     portion of our tobacco <font color="blue">curing barns</font></td>
    </tr>
    <tr>
      <td>Once the outstanding loan balance is     reduced to dlra10 million, the collateral will be released by B&amp;W As of the     end of 2005, we also had another note <font color="blue">payable <font color="blue">obligation</font></font> to B&amp;W in the     amount of dlra4cmam961cmam743</td>
    </tr>
    <tr>
      <td>Payments on this <font color="blue"><font color="blue">obligation</font> began</font> in January 2005 and     are due in <font color="blue">monthly principal payments</font> of dlra250cmam000 plus monthly interest     <font color="blue">payments at</font> prime plus 1prca on the <font color="blue">outstanding balance</font></td>
    </tr>
    <tr>
      <td><font color="blue">Pursuant to a <font color="blue">Hard Tobacco Agreement </font></font><font color="blue">entered into with</font> B&amp;W in April 2001,     B&amp;W  began  to  test market a <font color="blue">hard tobacco</font> product named Interval^® in     Louisville, Kentucky on <font color="blue">December </font>15, 2003, and a similar <font color="blue">dissolvable hard</font>     <font color="blue">tobacco product</font> in the summer of 2004</td>
    </tr>
    <tr>
      <td>In <font color="blue">December </font>2004, Star was notified     by RJR that the test market was not successful and that, as a result, the     <font color="blue">Hard Tobacco Agreement </font>was terminated</td>
    </tr>
    <tr>
      <td>In the past, B&amp;W has purchased <font color="blue">significant</font> quantities of StarCured^® tobacco     from us, which we in turn <font color="blue">purchased from</font> our <font color="blue">participating</font> StarCured^®     farmers</td>
    </tr>
    <tr>
      <td>B&amp;W has not purchased <font color="blue">tobacco from us</font> since 2004 and we have     advised our StarCured^® farmers that while they <font color="blue">could continue</font> to use the     barns,  they would need to find other buyers for their tobacco</td>
    </tr>
    <tr>
      <td>In the     future,  we  would like to resume purchasing tobacco directly from our     <font color="blue">participating</font> StarCured^® farmers, although our <font color="blue">agreement with</font> B&amp;W does not     require B&amp;W to purchase StarCured^® <font color="blue">tobacco from us</font> in the future</td>
    </tr>
    <tr>
      <td>In  <font color="blue">recent years</font>, B&amp;W has <font color="blue">granted us</font> a number of <font color="blue"><font color="blue">concessions</font> under</font> our     <font color="blue">agreements</font>, including <font color="blue">deferring interest</font> and principal payments, consenting     to our incurrence of <font color="blue">additional</font> indebtedness and agreeing to modify the Hard     Tobacco Agreement to allow us to pursue similar <font color="blue">licensing <font color="blue">arrangements</font> with</font>     <font color="blue">third parties</font></td>
    </tr>
    <tr>
      <td>B&amp;W’s failure to grant us similar <font color="blue">concessions</font> in the future     could have a number of <font color="blue">adverse consequences</font>, including restricting our     pursuit of business <font color="blue">opportunities with</font> B&amp;W or <font color="blue">third parties</font>, limiting our     ability to raise funds through debt financing and requiring payment of our     <font color="blue"><font color="blue">obligation</font>s</font> to them in <font color="blue">circumstances</font> where we may not have <font color="blue">sufficient funds</font>     available to do so</td>
    </tr>
    <tr>
      <td>We are <font color="blue">dependent</font> on the <font color="blue">domestic tobacco</font> business        All of our revenue for discount <font color="blue"><font color="blue">cigarette</font> sales</font> since 2000 was derived from     sales <font color="blue">in the United States</font></td>
    </tr>
    <tr>
      <td>The US <font color="blue"><font color="blue">cigarette</font> market</font> has <font color="blue">been contracting</font>     in <font color="blue">recent years</font> and <font color="blue">pricing pressures</font> in the <font color="blue">discount <font color="blue">cigarette</font></font> business     have <font color="blue">been increasing</font></td>
    </tr>
    <tr>
      <td><font color="blue">As the US </font><font color="blue"><font color="blue">cigarette</font> market</font> continues to contract,     this <font color="blue">trend could <font color="blue">adversely</font> affect</font> our <font color="blue">sales volumes</font>, operating income and     <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>The market for <font color="blue">smokeless products</font> is much <font color="blue">smaller than</font> the     market for smoked <font color="blue">tobacco product</font>s, and all of our <font color="blue">revenue from smokeless</font>     <font color="blue">tobacco product</font> sales to date has <font color="blue">been derived from</font> sales in the United     States, except for <font color="blue">de minimis amounts</font> of ARIVA^® sold in Bermuda, Turkey and     Norway</td>
    </tr>
    <tr>
      <td>Accordingly, we do not currently have access to <font color="blue">foreign markets</font> to     offset the impact of the declining US <font color="blue"><font color="blue">cigarette</font> market</font></td>
    </tr>
    <tr>
      <td><font color="blue">Competition </font>from other <font color="blue">tobacco companies could <font color="blue">adversely</font> affect us</font>        The <font color="blue">tobacco industry</font> is <font color="blue">highly competitive</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">primary competition</font> for     conventional <font color="blue"><font color="blue">cigarette</font>s</font> has been the “major” <font color="blue">cigarette</font> <font color="blue"><font color="blue">manufacture</font>rs</font>, each     of which has <font color="blue"><font color="blue">substantially</font> greater financial</font> and operating <font color="blue">resources than</font> we     do</td>
    </tr>
    <tr>
      <td>We have encountered <font color="blue">significant</font> competition from several other smaller     US  <font color="blue"><font color="blue">manufacture</font>rs</font>  of <font color="blue"><font color="blue">cigarette</font>s</font>, as well as importers of <font color="blue"><font color="blue">cigarette</font>s</font>     <font color="blue"><font color="blue">manufacture</font>d</font> in <font color="blue">foreign countries</font></td>
    </tr>
    <tr>
      <td>Many of these <font color="blue"><font color="blue">manufacture</font>rs</font> and importers     have <font color="blue"><font color="blue">substantially</font> greater financial</font>, <font color="blue">manufacturing</font>, marketing and other     <font color="blue">resources than</font> we do</td>
    </tr>
    <tr>
      <td><font color="blue">STONEWALL Hard Snuff</font>^® competes with major smokeless     <font color="blue"><font color="blue">manufacture</font>rs</font>,   and   ARIVA^®  competes  with  traditional  <font color="blue">cigarette</font>     <font color="blue"><font color="blue">manufacture</font>rs</font>, because ARIVA^® is <font color="blue">positioned as</font> an <font color="blue">alternative</font> to <font color="blue"><font color="blue">cigarette</font>s</font>     in situations where adult <font color="blue">cigarette</font> users cannot or choose not to smoke</td>
    </tr>
    <tr>
      <td>Those <font color="blue">companies <font color="blue">generally</font></font> have <font color="blue"><font color="blue">substantially</font> greater financial</font> and operating     <font color="blue">resources than</font> we do</td>
    </tr>
    <tr>
      <td>Also, these companies have a more <font color="blue">established presence</font>     in the smokeless <font color="blue">tobacco industry</font> than we do</td>
    </tr>
    <tr>
      <td>23     ______________________________________________________________________    [47]Table of Contents       Tobacco companies may use low-TSNA tobacco that does not <font color="blue">infringe on</font> the     <font color="blue">technology</font> to which we are the <font color="blue">exclusive licensee</font> or may develop <font color="blue">technology</font>     for low-TSNA tobacco that could make our <font color="blue">technology</font> obsolete        <font color="blue">Virtually </font>all flue-cured tobacco grown <font color="blue">in the United States</font> since 2001 has     <font color="blue">been cured</font> in a manner to reduce the levels of TSNAs</td>
    </tr>
    <tr>
      <td>At least one other     tobacco  company  has  begun  to incorporate low-TSNA tobacco into its     <font color="blue"><font color="blue">cigarette</font>s</font> products and others have begun to purchase low-TSNA tobacco and     are expected to incorporate that tobacco in their products</td>
    </tr>
    <tr>
      <td>If <font color="blue">competitors</font>     produce low-TSNA tobacco that does not <font color="blue">infringe on</font> the <font color="blue">technology</font> to which     we are the <font color="blue">exclusive licensee</font>, or develop other <font color="blue">tobacco product</font>s with less     toxins  that  can  <font color="blue">compete with</font> our very low-TSNA products, this could     <font color="blue">adversely</font>  affect  our  operating income and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>Additionally,     <font color="blue">competitors</font> may develop new <font color="blue">technology</font> for low-TSNA tobacco that could make     our current <font color="blue">technology</font> obsolete</td>
    </tr>
    <tr>
      <td>The <font color="blue">tobacco industry</font> is subject to substantial and <font color="blue">increasing regulation</font> and     taxation        Various federal, state and <font color="blue">local laws limit</font> the <font color="blue">advertising</font>, sale and use of     <font color="blue"><font color="blue">cigarette</font>s</font> and <font color="blue">smokeless <font color="blue">tobacco product</font>s</font>, and these laws have proliferated     in <font color="blue">recent years</font></td>
    </tr>
    <tr>
      <td>If this <font color="blue">trend continues</font>, it may have material and adverse     <font color="blue">effects on</font> our <font color="blue">sales volumes</font>, operating income and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>In addition,     <font color="blue"><font color="blue">cigarette</font>s</font> and <font color="blue">smokeless <font color="blue">tobacco product</font>s</font> are subject to substantial and     <font color="blue">increasing <font color="blue">excise taxes</font></font></td>
    </tr>
    <tr>
      <td>The <font color="blue">federal excise tax on</font> <font color="blue"><font color="blue">cigarette</font>s</font> rose from $</td>
    </tr>
    <tr>
      <td>The <font color="blue">federal excise tax on</font>     <font color="blue">smokeless <font color="blue">tobacco product</font>s</font> is <font color="blue">substantially</font> lower (dlra0dtta585 per pound)</td>
    </tr>
    <tr>
      <td>A     number of states have recently considered an increase in state <font color="blue">excise taxes</font>     on smoked and <font color="blue">smokeless <font color="blue">tobacco product</font>s</font></td>
    </tr>
    <tr>
      <td>While several states have no     excise  tax  on  smokeless  products,  tax  rates in other states vary     <font color="blue">considerably</font></td>
    </tr>
    <tr>
      <td>For example, the states of <font color="blue">Alabama and North Dakota </font>tax     <font color="blue">smokeless products</font> at a rate of 1dtta5 cents per ounce and 16 cents per ounce,     respectively, while the states of <font color="blue">North Carolina and Oregon </font>impose an excise     tax of 2prca and 65prca of wholesale cost, respectively</td>
    </tr>
    <tr>
      <td>Present state excise     taxes for <font color="blue"><font color="blue">cigarette</font>s</font> range from dlra0dtta30 per pack in Kentucky to dlra2dtta46 per pack     <font color="blue">in Rhode Island</font></td>
    </tr>
    <tr>
      <td><font color="blue">Increased </font><font color="blue">excise taxes</font> may result in declines in sales     volume for the <font color="blue">industry as</font> a whole</td>
    </tr>
    <tr>
      <td>This result could <font color="blue">adversely</font> affect our     operating income and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>In addition, several states have imposed     <font color="blue">additional</font> fees on <font color="blue"><font color="blue">cigarette</font>s</font> sold by <font color="blue"><font color="blue">manufacture</font>rs</font> who are not <font color="blue">signatories</font>     to the MSA or who have not <font color="blue">previously</font> entered into settlements with the     non-MSA states</td>
    </tr>
    <tr>
      <td>Such <font color="blue">additional</font> fees could <font color="blue">adversely</font> <font color="blue">impact on</font> our sales     volumes and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>Also, a number of states have passed statutes or     <font color="blue">regulations</font> requiring that <font color="blue"><font color="blue">cigarette</font>s</font> meet prescribed fire safety standards</td>
    </tr>
    <tr>
      <td>We have decided that it would not be <font color="blue">economically feasible</font> to develop a     separate <font color="blue">cigarette</font> for sale in these states, and we <font color="blue">will no longer sell</font>     <font color="blue"><font color="blue">cigarette</font>s</font>  in those states <font color="blue">once such statutes</font> and <font color="blue">regulations</font> go into     effect</td>
    </tr>
    <tr>
      <td>We  currently have <font color="blue">licenses from</font> the TTB to <font color="blue">manufacture</font> <font color="blue"><font color="blue">cigarette</font>s</font> and     <font color="blue">smokeless <font color="blue">tobacco product</font>s</font></td>
    </tr>
    <tr>
      <td>To the extent that we are unable to maintain our     current licenses or to obtain any <font color="blue">additional</font> licenses required by the TTB,     this <font color="blue">could materially</font> and <font color="blue">adversely</font> affect our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>In 1996, the FDA promulgated <font color="blue">regulations</font> governing the sale and <font color="blue">advertising</font>     of <font color="blue">tobacco product</font>s</td>
    </tr>
    <tr>
      <td>These <font color="blue">regulations</font> were <font color="blue">designed primarily</font> to discourage     the sale to, and consumption by, adolescents and children</td>
    </tr>
    <tr>
      <td>The authority of     the FDA to promulgate such <font color="blue">regulations</font> was challenged in the <font color="blue">federal courts</font></td>
    </tr>
    <tr>
      <td>On  March 21,  2000, the <font color="blue">United States </font>Supreme Court in a five to four     decision held that the <font color="blue">Congress </font>has not given the FDA authority to regulate     <font color="blue">tobacco product</font>s as customarily marketed</td>
    </tr>
    <tr>
      <td>Given the decision by the Supreme     Court it is <font color="blue">unclear whether</font> <font color="blue">Congress </font>will act to <font color="blue">grant <font color="blue">such authority</font></font> to the     FDA,  although  <font color="blue">legislation</font>  that would create <font color="blue">such authority</font> has been     introduced <font color="blue">previously</font> in Congress</td>
    </tr>
    <tr>
      <td>In late 2004, tobacco quota buyout <font color="blue">legislation</font> was <font color="blue">enacted into law which</font>     requires all tobacco <font color="blue">manufacture</font>s to pay for the cost of the <font color="blue">buyout over</font> the     next  ten  years</td>
    </tr>
    <tr>
      <td><font color="blue">Beginning </font>in January 2005, with the exception of the     <font color="blue">assessment</font>  noted  below,  we  have  been required to make payments of     <font color="blue">approximately</font> dlra0dtta50 per carton for our <font color="blue">cigarette</font> products and a comparable     cost for <font color="blue">smokeless <font color="blue">tobacco product</font>s</font></td>
    </tr>
    <tr>
      <td>As part of the program, we also will be     subject to <font color="blue"><font color="blue">assessment</font>s</font> for <font color="blue">certain loan loss costs</font> and <font color="blue"><font color="blue">administrative</font> costs</font></td>
    </tr>
    <tr>
      <td>These <font color="blue"><font color="blue">assessment</font>s</font> will be recorded when received and <font color="blue">paid over several</font>     quarters, rather than over the life of the <font color="blue">buyout program</font></td>
    </tr>
    <tr>
      <td>The Company, and     other <font color="blue">tobacco <font color="blue"><font color="blue">manufacture</font>rs</font></font> have increased prices to cover the cost of the     <font color="blue">buyout program</font></td>
    </tr>
    <tr>
      <td>While the increased cost could have a negative <font color="blue">impact on</font>     purchases of <font color="blue"><font color="blue">cigarette</font>s</font> by consumers, the impact of this added cost is     expected to be <font color="blue">proportional</font> across the industry</td>
    </tr>
    <tr>
      <td>We have substantial <font color="blue"><font color="blue">obligation</font>s</font> under state <font color="blue">laws adopted under</font> the Master     Settlement Agreement        Pursuant  to  the terms of the Master Settlement Agreement, we have an     <font color="blue">obligation</font> to <font color="blue">deposit into escrow accounts</font> a <font color="blue">base amount</font> equal to dlra3dtta35 per     carton in 2005-2006 and dlra3dtta77 per carton <font color="blue">each year</font> thereafter, for sales of     <font color="blue"><font color="blue">cigarette</font>s</font>  occurring  in the prior year in each <font color="blue">MSA Settling State</font></td>
    </tr>
    <tr>
      <td>A     <font color="blue">cumulative inflation adjustment</font> is also added to these <font color="blue">deposits at</font> the     higher of 3prca or the <font color="blue">Consumer Price Index </font><font color="blue">each year</font></td>
    </tr>
    <tr>
      <td>The failure to place such required     <font color="blue">amounts into escrow could</font> result in <font color="blue">severe penalties</font> to us and potential     <font color="blue">restrictions on</font> our ability to sell <font color="blue">tobacco product</font>s within particular     states</td>
    </tr>
    <tr>
      <td>Because of this escrow <font color="blue">requirement</font>, a substantial portion of our net     income from <font color="blue">operations</font> has been unavailable for our use and the amount     required to be placed in escrow for <font color="blue">each carton</font> sold may exceed the net cash     flow  generated  by <font color="blue">each carton</font> sold</td>
    </tr>
    <tr>
      <td>As a result, we have experienced     negative <font color="blue">cash flows</font> from <font color="blue">operations</font>, which, among other things, has affected     our ability to apply the capital generated from our present <font color="blue"><font color="blue">cigarette</font> sales</font>     to the <font color="blue">further scientific <font color="blue">development</font></font> of less toxic and <font color="blue">potentially</font> less     hazardous <font color="blue">tobacco product</font>s and to the growth of our business</td>
    </tr>
    <tr>
      <td>In addition,     the <font color="blue">escrow <font color="blue"><font color="blue">obligation</font>s</font></font> will impede our ability to <font color="blue">distribute dividends</font> to     our <font color="blue">stockholders</font></td>
    </tr>
    <tr>
      <td>24     ______________________________________________________________________    [48]Table of Contents       We have tried to mitigate the costs of the MSA by focusing our <font color="blue">field sales</font>     force and our <font color="blue">efforts on increasing market</font> share in states that were not     <font color="blue">participants</font> in the MSA, among other approaches</td>
    </tr>
    <tr>
      <td><font color="blue">The MSA States </font>have taken     the position that <font color="blue">the Company </font>is responsible to <font color="blue">escrow funds</font> for any sales     in MSA States whether made by ST directly or by a <font color="blue">third party</font> to whom ST has     <font color="blue">sold product</font></td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>is in full compliance for <font color="blue">escrow <font color="blue"><font color="blue">obligation</font>s</font></font>     through 2005 and currently has <font color="blue">approximately</font> dlra37dtta3 million in escrow</td>
    </tr>
    <tr>
      <td>In addition, most of the MSA states have <font color="blue">enacted statutes</font> that require     non-<font color="blue">participating</font> <font color="blue"><font color="blue">manufacture</font>rs</font> to certify that they are in full compliance     with the escrow <font color="blue">requirement</font>s of the MSA as a condition to being permitted to     sell <font color="blue">cigarette</font> products in those states</td>
    </tr>
    <tr>
      <td><font color="blue">While <font color="blue">the Company </font></font>has recently     focused its sales in the four states that are not part of the MSA, failure     to <font color="blue">comply with</font> these statutes would negatively <font color="blue">impact on</font> the Company’s     ability  to  sell  <font color="blue"><font color="blue">cigarette</font>s</font> in those MSA states, <font color="blue">notwithstanding</font> our     substantial <font color="blue">payments into escrow</font></td>
    </tr>
    <tr>
      <td>We may be assessed <font color="blue">additional</font> sales and use taxes by the <font color="blue">Commonwealth </font>of     Virginia        In a letter dated October 7, 2004, <font color="blue">the Company </font>received <font color="blue">notification from</font>     the <font color="blue">Commonwealth </font>of Virginia that an <font color="blue">adverse decision</font> had been made by the     <font color="blue"><font color="blue">Commissioner </font>of Taxation </font><font color="blue">with respect</font> to the sales and use tax <font color="blue">assessment</font>     <font color="blue">previously</font> issued to <font color="blue">the Company </font>and that the sales and use tax <font color="blue">assessment</font>     plus  penalties  and interest together, as <font color="blue">of October </font>7, 2004, totaled     <font color="blue">approximately</font> dlra988cmam000</td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>continues to challenge this <font color="blue">assessment</font>     and  has  filed a request for <font color="blue">reconsideration with</font> the <font color="blue">Commissioner </font>of     Taxation, and is prepared to file a judicial action if the <font color="blue">administrative</font>     action is not favorable</td>
    </tr>
    <tr>
      <td>The filing of the request for <font color="blue">reconsideration stays</font>     any <font color="blue">collection</font> of the tax <font color="blue">assessment</font>, although interest continues to accrue</td>
    </tr>
    <tr>
      <td><font color="blue">While <font color="blue">the Company </font></font>is optimistic that its request for <font color="blue">reconsideration will</font> be     <font color="blue">accepted based on prior rulings</font> in similar cases, if the <font color="blue">assessment</font> is not     reversed,  the  Company will be required to pay the tax, penalties and     <font color="blue">interest due</font></td>
    </tr>
    <tr>
      <td>Lawsuits may affect our <font color="blue">profitability</font>; we have limited insurance coverage        We  are  not, nor have we ever been, named as a <font color="blue">defendant</font> in any legal     <font color="blue">proceedings</font>  involving  claims  arising out of the sale, <font color="blue">distribution</font>,     <font color="blue">manufacture</font>, <font color="blue">development</font>, <font color="blue">advertising</font>, marketing and claimed <font color="blue">health effects</font>     relating to the use of our <font color="blue">tobacco product</font>s</td>
    </tr>
    <tr>
      <td>While we believe that the risk     of being named a <font color="blue">defendant</font> in such a lawsuit is <font color="blue">relatively low</font>, we may be     named as a <font color="blue">defendant</font> in the <font color="blue">future as there</font> has been a <font color="blue">noteworthy increase</font>     in the number of these <font color="blue">cases pending</font></td>
    </tr>
    <tr>
      <td>Punitive damages, often in amounts     <font color="blue">ranging into</font> the hundreds of millions, or <font color="blue">even billions</font> of dollars, are     <font color="blue">specifically pleaded</font> in a number of these cases in addition to <font color="blue">compensatory</font>     and other damages</td>
    </tr>
    <tr>
      <td>In the past, we maintained product <font color="blue">liability</font> insurance     only <font color="blue">with respect</font> to claims that <font color="blue">tobacco product</font>s <font color="blue"><font color="blue">manufacture</font>d</font> by or for us     contained any foreign object, ie any object that is not intended to be     included in the <font color="blue"><font color="blue">manufacture</font>d</font> product</td>
    </tr>
    <tr>
      <td>The product <font color="blue">liability</font> insurance we <font color="blue">previously</font> maintained did not     cover health-related claims such as those that have been made against the     major  <font color="blue"><font color="blue">manufacture</font>rs</font>  of <font color="blue">tobacco product</font>s</td>
    </tr>
    <tr>
      <td>We do not believe that such     <font color="blue">insurance currently</font> can be obtained</td>
    </tr>
    <tr>
      <td>Accordingly, our inclusion in any of     these actions or any <font color="blue">future action could</font> have a material and adverse effect     on our <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>In addition, beginning in 2001, we <font color="blue">embarked on</font>     the test market and <font color="blue">distribution</font> of new <font color="blue">smokeless <font color="blue">tobacco product</font>s</font></td>
    </tr>
    <tr>
      <td>To the     extent  the  sale  and  <font color="blue">distribution</font>  of  such products results in any     health-related claims, such claims could have a material and adverse effect     on our <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>We may not <font color="blue">properly manage</font> our growth        If we are successful in increasing market <font color="blue">acceptance</font> for our products, we     will  be  required to manage substantial <font color="blue">volume from</font> our customers</td>
    </tr>
    <tr>
      <td>To     <font color="blue">accommodate</font> any <font color="blue">such growth</font> and <font color="blue">compete <font color="blue">effective</font>ly</font>, we will be required to     attract, integrate, motivate and retain <font color="blue">additional</font> highly skilled sales,     technical and other employees</td>
    </tr>
    <tr>
      <td>We <font color="blue">face competition</font> for these people</td>
    </tr>
    <tr>
      <td>Our     ability to <font color="blue">successfully manage such volume also will</font> be <font color="blue">dependent</font> on our     ability to scale up our <font color="blue">tobacco processing</font> and production <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue">There     </font>can be no assurance that we can overcome the challenge of <font color="blue">scaling up</font> our     processing  and  production <font color="blue">operations</font> or that our personnel, systems,     procedures and <font color="blue">controls will</font> be adequate to support our future <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Any  failure  to  implement and improve our operational, financial and     <font color="blue"><font color="blue">management</font> systems</font> or to attract, integrate, motivate and retain <font color="blue">additional</font>     employees required <font color="blue">by future growth</font>, if any, could have a material and     adverse  effect on our business and prospects, <font color="blue">financial condition</font> and     results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We may not be successful in protecting our <font color="blue">intellectual property rights</font>        Our  success  in  <font color="blue">commercially</font>  exploiting our <font color="blue">licensed tobacco curing</font>     <font color="blue">technology</font> and low-TSNA <font color="blue">smokeless <font color="blue">tobacco product</font>s</font> depends in large part on     our ability to <font color="blue">defend issued patents</font>, to obtain <font color="blue">further patent protection</font>     for the <font color="blue">technology</font> <font color="blue">in the United States</font> and other <font color="blue">jurisdictions</font>, and to     operate  <font color="blue">without infringing upon</font> the patents and <font color="blue">proprietary rights</font> of     others</td>
    </tr>
    <tr>
      <td>25     ______________________________________________________________________    [49]Table of Contents       Additionally, we must be able to obtain <font color="blue">appropriate licenses</font> to patents or     <font color="blue">proprietary rights</font> held by <font color="blue">third parties</font> if <font color="blue">infringement</font> would otherwise     occur, both <font color="blue">in the United States</font> and in <font color="blue">foreign countries</font></td>
    </tr>
    <tr>
      <td>Patent  positions  are uncertain and <font color="blue">involve complex legal</font> and factual     questions for <font color="blue">which important legal principles</font> are unresolved</td>
    </tr>
    <tr>
      <td>Any conflicts     resulting  from  third  party  patent  <font color="blue">applications</font>  and patents could     <font color="blue">significant</font>ly reduce the coverage of our patents and limit our ability to     obtain  <font color="blue">meaningful</font>  patent  protection</td>
    </tr>
    <tr>
      <td>If patents are issued to other     companies that <font color="blue">contain competitive</font> or <font color="blue">conflicting</font> claims, we may be required     to obtain licenses to these patents or to develop or obtain <font color="blue">alternative</font>     <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>Such licensing <font color="blue">agreements</font>, if required, may not be <font color="blue">available on</font>     acceptable terms or at all</td>
    </tr>
    <tr>
      <td>If <font color="blue">such licenses</font> are not obtained, we could be     delayed in or <font color="blue">prevented from pursuing</font> the <font color="blue">development</font> or <font color="blue">commercialization</font>     of our products</td>
    </tr>
    <tr>
      <td>Litigation, <font color="blue">which could</font> result in substantial cost, may also be <font color="blue">necessary</font> to     enforce any patents to which we have rights, or to determine the scope,     validity and <font color="blue">unenforceability</font> of other parties’ <font color="blue">proprietary rights</font> which may     affect our rights</td>
    </tr>
    <tr>
      <td>There are <font color="blue">always risks</font> in any <font color="blue">litigation</font></td>
    </tr>
    <tr>
      <td>US patents     carry  a <font color="blue">presumption</font> of validity and <font color="blue">generally</font> can be <font color="blue">invalidated only</font>     <font color="blue">through clear</font> and <font color="blue">convincing evidence</font></td>
    </tr>
    <tr>
      <td>We may also have to <font color="blue">participate</font> in     interference <font color="blue">proceedings</font> declared by the <font color="blue">US Patent and Trademark Office </font>to     determine the priority of an invention, <font color="blue">which could</font> result in substantial     cost to the Company</td>
    </tr>
    <tr>
      <td>In particular, we are <font color="blue">currently prosecuting patent</font>     <font color="blue">infringement</font> claims against RJR in a <font color="blue">consolidated action</font> in the United     States District Court for the District of Maryland</td>
    </tr>
    <tr>
      <td>In the coming months, we     anticipate increases in general and <font color="blue"><font color="blue">administrative</font> costs</font> in <font color="blue">connection</font> with     the continued <font color="blue">prosecution</font> of our patent <font color="blue">infringement</font> lawsuits</td>
    </tr>
    <tr>
      <td>Moreover, the     mere <font color="blue">uncertainty</font> resulting from the <font color="blue">institution</font> and <font color="blue">continuation</font> of any     <font color="blue">technology</font>-related  <font color="blue">litigation</font> or <font color="blue">interference proceeding could</font> have a     material and adverse effect on our business and prospects</td>
    </tr>
    <tr>
      <td>We <font color="blue">may also rely on unpatented <font color="blue">trade secrets</font></font> and know-how to maintain our     competitive position, which we seek to protect, in part, <font color="blue">by confidentiality</font>     <font color="blue">agreements</font> with employees, consultants, suppliers and others</td>
    </tr>
    <tr>
      <td>There can be     no assurance that these <font color="blue">agreements</font> will not be breached or terminated, that     we will have <font color="blue">adequate remedies</font> for any breach, or that our <font color="blue">trade secrets</font>     will  not  otherwise  become  known  or be in<font color="blue">dependent</font>ly discovered by     <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on <font color="blue">key personnel</font></font>        We <font color="blue">depend upon</font> the <font color="blue">continued services</font> of our <font color="blue">senior <font color="blue">management</font> team</font> for our     <font color="blue">continued success</font></td>
    </tr>
    <tr>
      <td>The loss of any one of the Company’s Chief Executive     Officer, Jonnie R Williams, the Company’s Chairman, President and Chief     Operating  Officer,  Paul  L  Perito, the Vice President of Sales and     Marketing, David M Dean, the Company’s Chief Financial Officer, Christopher     G Miller or the Company’s General Counsel, Robert E Pokusa, could have a     <font color="blue">serious negative impact upon</font> our business and operating results</td>
    </tr>
    <tr>
      <td>The Company’s <font color="blue">success depends</font> in large part on its ability to attract and     retain, on a continuing basis, consulting services from highly qualified     scientific,  technical, <font color="blue">management</font>, financial and <font color="blue">marketing personnel</font></td>
    </tr>
    <tr>
      <td><font color="blue">Competition </font>for such personnel is intense and there can be no assurance that     <font color="blue">the Company </font>will be able to attract and retain the personnel <font color="blue">necessary</font> for     the <font color="blue">development</font> and operation of our business or that given the losses that     <font color="blue">the Company </font>has <font color="blue">suffered over</font> the <font color="blue">past three years</font> that we will have the     <font color="blue">financial ability</font> to do so</td>
    </tr>
    <tr>
      <td>The loss of the services of <font color="blue">key personnel</font> or the     <font color="blue">termination</font>  of  contracts  with  in<font color="blue">dependent</font>  scientific  and medical     <font color="blue">investigators could</font> have a material and adverse effect on the Company’s     business</td>
    </tr>
    <tr>
      <td><font color="blue">Management </font>and <font color="blue">significant</font> <font color="blue">stockholders</font> can exercise influence over the     Company        Based <font color="blue">upon stock ownership as</font> of <font color="blue">December </font>31, 2005, our <font color="blue">executive officers</font>,     <font color="blue">directors</font> and their <font color="blue">associates</font>, own an aggregate of <font color="blue">approximately</font> 30dtta5prca of     our <font color="blue">outstanding shares</font></td>
    </tr>
    <tr>
      <td>As a result, these persons acting together may have     the ability to control matters submitted to our <font color="blue">stockholders</font> for approval     and to control the <font color="blue">management</font> and affairs of the Company</td>
    </tr>
    <tr>
      <td>This <font color="blue">concentration</font>     of <font color="blue">ownership may</font> have the effect of delaying or preventing a change in     control of the Company, impede a merger, consolidation, or takeover or other     business <font color="blue">combination</font>, or discourage a <font color="blue">potential acquirer from attempting</font> to     obtain control</td>
    </tr>
    <tr>
      <td>This <font color="blue">concentration</font> of <font color="blue">control could also</font> have a negative     effect on the <font color="blue">market price</font> of our shares</td>
    </tr>
    <tr>
      <td>Our stock price has been and <font color="blue">may continue</font> to be volatile and an <font color="blue">investment</font>     in our <font color="blue">common stock</font> could suffer a decline in value        The  trading  price of the shares of our <font color="blue">common stock</font> has been and may     continue to be <font color="blue">highly volatile</font></td>
    </tr>
    <tr>
      <td>Since 2004, our stock has <font color="blue">traded at prices</font>     ranging from dlra1dtta70 on January 14, 2004, to dlra7dtta10 on <font color="blue">February </font>4, 2005, and     dlra2dtta35 on <font color="blue">December </font>30, 2005</td>
    </tr>
    <tr>
      <td>We receive only limited <font color="blue">attention by securities</font>     analysts and may experience an <font color="blue">imbalance between supply</font> and demand for our     <font color="blue">common stock</font> resulting <font color="blue">from low trading volumes</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">market price</font> of our     common  stock  may fluctuate <font color="blue">significant</font>ly in response to a variety of     factors, most of which are beyond our control, including the following:           •   <font color="blue">development</font>s related to our patents or other <font color="blue">proprietary rights</font>,     including <font color="blue">development</font>s in our <font color="blue">litigation</font> against RJR;                                           26     ______________________________________________________________________    [50]Table of Contents         •   <font color="blue">development</font>s in our efforts to market <font color="blue">smokeless <font color="blue">tobacco product</font>s</font>;           •   <font color="blue">announcements by us</font> or our <font color="blue">competitors</font> of new products, technological     innovations, contracts, acquisitions, <font color="blue">financings</font>, corporate partnerships or     <font color="blue">joint ventures</font>;           •   negative <font color="blue">regulatory</font> action or <font color="blue">regulatory</font> approval <font color="blue">with respect</font> to our     products or our <font color="blue">competitors</font>’ products; and           •   <font color="blue">market conditions</font> for the <font color="blue">tobacco industry</font> in general</td>
    </tr>
    <tr>
      <td>The <font color="blue">stock market</font> has, from time to time, experienced <font color="blue">extreme price</font> and     volume fluctuations, which have <font color="blue">particularly</font> affected the <font color="blue">market price</font>s for     small companies and which have <font color="blue">often been unrelated</font> to their operating     performance</td>
    </tr>
    <tr>
      <td>These broad fluctuations may <font color="blue">adversely</font> impact the <font color="blue">market price</font>     of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>In addition, sales of substantial amounts of our common     stock in the <font color="blue">public market could lower</font> the <font color="blue">market price</font> of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>Future sales of our <font color="blue">common stock</font> would have a dilutive effect on current     <font color="blue">stockholders</font>        If  we  issue <font color="blue">additional</font> shares of our <font color="blue">common stock</font> for sale in future     <font color="blue">financings</font>, our <font color="blue">stockholders</font> would experience dilution</td>
    </tr>
    <tr>
      <td>Our research &amp; <font color="blue">development</font> efforts may not result in <font color="blue">commercially</font> viable     products and <font color="blue">may continue</font> to be <font color="blue">curtailed by</font> our lack of <font color="blue">available research</font>     funds        <font color="blue">Consistent </font>with our efforts to cut costs, <font color="blue">the Company </font><font color="blue">deferred certain</font>     research projects beginning in the last half of 2003</td>
    </tr>
    <tr>
      <td>We expect our spending     on research for 2006 to be at a de minimis level, while we continue to     <font color="blue">concentrate</font> our efforts and <font color="blue">resources on</font> our <font color="blue">ongoing patent <font color="blue">infringement</font></font>     <font color="blue">lawsuit against</font> RJR Presently, our <font color="blue">research focus</font> is directed to assessing     the impact that <font color="blue">products with reduced toxin levels may</font> have on the range of     <font color="blue">serious health hazards associated with</font> the use of <font color="blue">conventional smoked</font> and     <font color="blue">smokeless <font color="blue">tobacco product</font>s</font></td>
    </tr>
    <tr>
      <td>While our research work has been deferred as a     result of the lack of available working capital, <font color="blue">the Company </font>has designed     several <font color="blue">additional</font> scientific studies to assess, among other things, whether     a  reduction  in TSNAs can be equated with a reduction in <font color="blue">health risk</font>,     <font color="blue">biomarker differences</font> that can be equated to levels of <font color="blue">various toxins</font> in     <font color="blue">smoked versus smokeless tobacco</font>, and the impact of the decline in TSNA     exposure in low-TSNA smokeless tobacco compared to traditional <font color="blue">cigarette</font>     products</td>
    </tr>
    <tr>
      <td>However, because of <font color="blue">monetary constraints</font> we are not moving forward     with these <font color="blue">studies at</font> this time</td>
    </tr>
    <tr>
      <td>When we initiate these studies, they will     be conducted by in<font color="blue">dependent</font> laboratories and <font color="blue">universities</font></td>
    </tr>
    <tr>
      <td>We hope to renew     our research and <font color="blue">development</font> efforts in 2006, subject to the <font color="blue">availability</font> of     funds</td>
    </tr>
    <tr>
      <td>However, <font color="blue">such research may</font> not result in <font color="blue">new products reaching</font> the     market, or in any <font color="blue">improvement</font>s to our <font color="blue">current products</font></td>
    </tr>
    <tr>
      <td>This could occur for     a number of reasons, including if <font color="blue">potential new products</font>:           •   fail to receive any <font color="blue">necessary</font> <font color="blue">regulatory</font> approvals on a <font color="blue">timely basis</font>     or at all;           •   are precluded from <font color="blue">commercialization</font> by <font color="blue">proprietary rights</font> of third     parties; or           •   are uneconomical or fail to achieve market <font color="blue">acceptance</font></td>
    </tr>
    <tr>
      <td>Failure to develop new products or to improve our <font color="blue">current products</font> could     have a material and adverse <font color="blue">impact on</font> our net sales, operating income and     <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>If we fail to maintain an <font color="blue">effective</font> system of <font color="blue">internal controls</font>, we may not     be able to <font color="blue">accurately</font> report our financial results, as a result, current and     potential <font color="blue">stockholders</font> could <font color="blue">lose confidence</font> in our financial reporting,     <font color="blue"><font color="blue">which could</font> harm</font> our business and our stock price        The  Company  has <font color="blue">previously</font> determined that its <font color="blue">internal control over</font>     financial reporting is <font color="blue">effective</font> and our <font color="blue">outside auditors</font> have issued a     report <font color="blue">concurring</font> in that <font color="blue">assessment</font></td>
    </tr>
    <tr>
      <td><font color="blue">If <font color="blue">the Company </font></font>fails to maintain its     <font color="blue">internal controls</font> over financial reporting, this could cause investors to     <font color="blue">lose confidence</font> in our reported financial information, <font color="blue">which could</font> have a     negative <font color="blue">impact on</font> the <font color="blue">trading price</font> for our stock</td>
    </tr>
  </tbody>
</table>